Company intelligence / Profile preview

NanoDx

Southborough, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

The NanoDx™ System (and Tbit™ System) provides rapid, real-time diagnostic results for TBI and concussion, validated in clinical studies, but not yet FDA-approved. The company reports strong investor and clinical interest with an accelerated development and application roadmap.

Therapeutic areas: Infectious DiseasesNeurology
Modalities: DeviceNanoparticle
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on NanoDx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoDx.

Explore the full profile